157 related articles for article (PubMed ID: 17038803)
1. Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain.
Yanagida T; Takata K; Inden M; Kitamura Y; Taniguchi T; Yoshimoto K; Taira T; Ariga H
J Pharmacol Sci; 2006 Oct; 102(2):243-7. PubMed ID: 17038803
[TBL] [Abstract][Full Text] [Related]
2. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
3. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
[TBL] [Abstract][Full Text] [Related]
4. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
5. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
[TBL] [Abstract][Full Text] [Related]
6. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway.
Urano Y; Mori C; Fuji A; Konno K; Yamamoto T; Yashirogi S; Ando M; Saito Y; Noguchi N
Autophagy; 2018; 14(11):1943-1958. PubMed ID: 30112966
[TBL] [Abstract][Full Text] [Related]
7. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1.
Nunome K; Miyazaki S; Nakano M; Iguchi-Ariga S; Ariga H
Biol Pharm Bull; 2008 Jul; 31(7):1321-6. PubMed ID: 18591768
[TBL] [Abstract][Full Text] [Related]
8. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
[TBL] [Abstract][Full Text] [Related]
9. Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.
Lev N; Barhum Y; Ben-Zur T; Melamed E; Steiner I; Offen D
J Mol Neurosci; 2013 Jul; 50(3):542-50. PubMed ID: 23536331
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death.
Kim SJ; Park YJ; Hwang IY; Youdim MB; Park KS; Oh YJ
Free Radic Biol Med; 2012 Aug; 53(4):936-50. PubMed ID: 22683601
[TBL] [Abstract][Full Text] [Related]
11. Hinokitiol Offers Neuroprotection Against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes.
Varier KM; Sumathi T
Neurotox Res; 2019 May; 35(4):945-954. PubMed ID: 30569287
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione.
Miyama A; Saito Y; Yamanaka K; Hayashi K; Hamakubo T; Noguchi N
PLoS One; 2011; 6(11):e27883. PubMed ID: 22132160
[TBL] [Abstract][Full Text] [Related]
13. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.
Aleyasin H; Rousseaux MW; Phillips M; Kim RH; Bland RJ; Callaghan S; Slack RS; During MJ; Mak TW; Park DS
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18748-53. PubMed ID: 18003894
[TBL] [Abstract][Full Text] [Related]
14. DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging.
Lev N; Barhum Y; Pilosof NS; Ickowicz D; Cohen HY; Melamed E; Offen D
J Gerontol A Biol Sci Med Sci; 2013 Mar; 68(3):215-25. PubMed ID: 22887838
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
[TBL] [Abstract][Full Text] [Related]
16. Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7.
Yanagida T; Kitamura Y; Yamane K; Takahashi K; Takata K; Yanagisawa D; Yasui H; Taniguchi T; Taira T; Honda T; Ariga H
J Pharmacol Sci; 2009 Mar; 109(3):463-8. PubMed ID: 19276614
[TBL] [Abstract][Full Text] [Related]
17. Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.
Inden M; Kitamura Y; Takata K; Yasui H; Yoshimoto K; Ashihara E
Biol Pharm Bull; 2012; 35(9):1603-6. PubMed ID: 22975516
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.
Maasz G; Zrinyi Z; Reglodi D; Petrovics D; Rivnyak A; Kiss T; Jungling A; Tamas A; Pirger Z
Dis Model Mech; 2017 Feb; 10(2):127-139. PubMed ID: 28067625
[TBL] [Abstract][Full Text] [Related]
19. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals.
Akazawa YO; Saito Y; Hamakubo T; Masuo Y; Yoshida Y; Nishio K; Shichiri M; Miyasaka T; Iwanari H; Mochizuki Y; Kodama T; Noguchi N; Niki E
Neurosci Lett; 2010 Oct; 483(3):201-5. PubMed ID: 20708070
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
